Emergent BioSolutions (United States)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
65%
Total
Publications
390
Total Open
Publications
255
Total
Citations
12K
Open Access
Percentage
65%
Total
Publications
390
Total Open
Publications
255
Total
Citations
12K
Breakdown
Publisher Open
23%
Both
32%
Other Platform Open
9%
Closed
36%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 53%
112
Hybrid 22%
46
No Guarantees 25%
52
Other Platform Open
Domain 70%
113
Other Internet 24%
39
Institution 20%
33
Public 6%
10
Preprint 5%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 112 |
DOI | Other Internet | 40 |
Figshare | Public | 7 |
arXiv | Preprint | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
Europe PMC | Domain | 4 |
University of South Florida | Institution | 3 |
Office of Scientific and Technical Information | Institution | 3 |
epfl.ch OAI-PMH Repository | Institution | 3 |
bioRxiv | Preprint | 3 |